Üks Life4me+ peamiseid eesmärke on uute HIVi- ja muude sugulisel teel levivate nakkuste juhtumite, nagu ka C-hepatiiti ja tuberkuloosi nakatumise ennetamine.

Nutirakendus aitab luua kontakti arstide ja HIV positiivsete inimeste vahel. Nutirakendus aitab mugavalt organiseerida ravimite võtmise aegu, seadistada ainult Teile arusaadavad ja personaalseid meeldetuletusi, võimaldab saada arstilt tagasisidet ning panna aega vastuvõtule või analüüsidele.

Kõik uudised / Veebruar 2021

Arhiiv

✕

28 veebruar 2021

2405

New study to tackle HIV multi-drug resistance launches

New study to tackle HIV multi-drug resistance launches

In London and Edinburgh, researchers have begun recruiting participants for a new study aimed at better understanding and overcoming HIV multi-drug resistance. On week one participants will be randomised to one of four blinded arms. Alongside their current, failing, ...

28 veebruar 2021

3349

South Africa eyes up Sputnik vaccine

South Africa eyes up Sputnik vaccine

South African authorities have been working to assess the Russian Sputnik V vaccine this week, reports TASS, citing Bloomberg. The countries health experts and regulators are considering the possibility of using the Russian vaccine for mass vaccination in the republic. The ...

28 veebruar 2021

2477

UN to host high-level meeting on HIV & AIDS

UN to host high-level meeting on HIV & AIDS

The United Nations will host a high-level Meeting on HIV & AIDS from 8-10 June 2021 according to the UNAIDS website. During the event world leaders will come together to discuss the five-year results of their combined work to reduce the impact of HIV. The high-level meeting ...

28 veebruar 2021

2508

ViiV Healthcare applies for new injectable regimen approval

ViiV Healthcare applies for new injectable regimen approval

In January 2021 the US Food and Drug Administration (FDA) approved the use of the injectable HIV treatment, Cabenuva. Now ViiV Healthcare has filed an application to expand the product labelling to include bi-monthly dosing. Data from the Phase III ATLAS-2M trial, which ...

28 veebruar 2021

3082

Pfizer BioNTech vaccine shows 94% efficacy in Israel

Pfizer BioNTech vaccine shows 94% efficacy in Israel

The COVID-19 vaccine developed and produced by Pfizer and BioNTech has shown 94% efficacy following the vaccination of more than 590,000 people in Israel, according to a study published in The New England Journal of Medicine. According to the study at day 14 through 20 ...

25 veebruar 2021

2732

The indirect impact of COVID-19 on HIV morbidity and mortality

The indirect impact of COVID-19 on HIV morbidity and mortality

A number of studies over the past twelve months have differed in their conclusions when it comes to the risk COVID-19 poses to people living with HIV. Some found no difference in the incidence and outcomes of COVID-19 for people living with HIV, whilst others found just ...

25 veebruar 2021

2745

Estonia and Latvia: Opposite approaches in the fight against HIV

Estonia and Latvia: Opposite approaches in the fight against HIV

In Eastern Europe two neighbouring countries are taking two very different approaches in their response to the rise in HIV amongst people who use drugs. Whilst distribution of sterile needles and syringes, HIV testing and affordable treatment have helped reduce the number ...

25 veebruar 2021

2271

Lancet: Minorities continue to be most impacted by US HIV epidemic

Lancet: Minorities continue to be most impacted by US HIV epidemic

A series of six articles in The Lancet has laid bare the continuing HIV epidemic in the United States. Whilst diagnoses rates are improving in the more affluent northern states and amonst white people things are heading the other way for people of colour, those who inject ...

25 veebruar 2021

2307

Manufacturers adapt vaccines to protect against new strains of coronavirus

Manufacturers adapt vaccines to protect against new strains of coronavirus

American biotech company Moderna is one of the first to announce the start of clinical trials of a new version of their COVID-19 vaccine which is hoped will offer effective protection against the “South African” strain of the virus. Currently, the coronavirus strain causing ...

18 veebruar 2021

2640

“No HIV stigma” became the motto of 2019 for Life4me+

“No HIV stigma” became the motto of 2019 for Life4me+

Today, Life4me+ published its annual progress report for 2019. The long delay has been due to the unfolding coronavirus pandemic that swept the world over the past twelve months. 2019 was a bright year for the organisation, filled with events & fruitful projects. Life4me+ ...

1 2 3